Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose H5N1 Vaccine in Healthy Adults
NCT00311675Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2006
- Primary completion
- Dec 2006
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of influenza A/Vietnam/1203/2004 (H5N1) vaccine in Avian influenza A H5N1 infection (H5N1), sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2006; status: completed.
02
Drugs
influenza A/Vietnam/1203/2004 (H5N1) vaccine
03
Conditions
Avian influenza A H5N1 infection (H5N1)
Beyond the preview
Go deeper on NCT00311675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311675.